Industrial College of the Armed Forces Industry Studies 2003: Biotechnology
Abstract
Biotechnology is a discipline that integrates biology, chemistry, physiology, information technology, engineering, and nanotechnology with the potential to revolutionize every aspect of modern life. This critical sector of United States industry is developing products that will improve health care, agriculture, industrial processes, and environmental remediation and provides the foundation of national biological defense. Millions of people worldwide benefit from revolutionary vaccines, antibiotics, drug therapies, and new medical devices. Agricultural advances include crops engineered to be pest resistant, to survive extreme climates, and to produce additional nutrients or therapeutics. Biotechnology, from vaccines to sensors to biometrics, is a cornerstone of homeland defense. However, many ethical issues abound, from stem cell research limitations to acceptance of foodstuffs from genetically modified crops to policies for vaccination against bioterrorism. Because of long product research, development, and testing times, many promising ideas run out of cash. In the wake of a financial downturn, venture capitalists are cautious, and many small companies simply expire. Inefficiencies plague huge investments made by the U.S. government. Despite economic challenges, the biotechnology industry is poised to be a major factor in the growth of pharmaceutical and agriculture sectors of the U.S. economy. As we enter the "Era of the Biomolecule," the United States must implement policies and allocate resources to maintain its lead in biotechnology for national security and economic power.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2003
- Accession Number
- ADA425466
Entities
People
- Abdelaziz Aichouche
- Brent E. Blaschke
- Charles R. Fellows
- Jeanne M. Brooks
- Michael D. Bergman
Organizations
- Dwight D. Eisenhower School for National Security and Resource Strategy